Question 1

What is Kelvin Stott?

Accepted Answer

Kelvin Stott is a Person.

Question 2

How often does Kelvin Stott appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Kelvin Stott first tracked by Ergen?

Accepted Answer

First tracked on Apr 19, 2026.

Question 4

When was Kelvin Stott last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is Kelvin Stott's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Kelvin Stott in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Kelvin Stott?

Accepted Answer

SynSmart, Amporin Collaborate on Therapeutics (Apr 19, 2026, 7 articles).

Question 8

How did the "SynSmart, Amporin Collaborate on Therapeutics" event impact Kelvin Stott?

Accepted Answer

Kelvin Stott, Founder and CEO at Amporin Pharmaceuticals AG, expressed excitement about the collaboration, emphasizing its potential to accelerate drug development.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.